Biotech Values

[DewDiligence]

PFE/AZN—Nobel laureate (and former president of Rockefeller University), Paul Nurse says PFE’s 5-year commitment to UK-based R&D is inadequate:

http://www.reuters.com/article/2014/05/14/us-astrazeneca-pfizer-idUSBREA3R0H520140514

Nobel laureate Paul Nurse, the president of the Royal Society, Britain's national academy of science, wrote to the chairman of Parliament's science committee Andrew Miller to express his concern that Pfizer's promises so far were vague and inadequate…. “A five-year commitment to the UK is insufficient. A commitment of at least 10 years is required. Science is not a quick win,” he wrote.